ENCISION INC (ECIA) — SEC Financial Statements & Analysis

ENCISION INC (ECIA) is a surgical & medical instruments & apparatus company, incorporated in CO. ENCISION INC trades on OTC as: ECIA. ENCISION INC (ECIA)'s most recent SEC filing is a Form 10-Q for the period ended 2025-09-30, filed with the SEC on 2025-11-13. Based on that filing, ENCISION INC carries a market cap of $5.48M, a P/E ratio of -14.38x, a P/B ratio of 2.94x, a P/S ratio of 0.87x, an enterprise value of $5.63M, and an EV/EBITDA multiple of -24.26x. On profitability, it posts a gross margin of 52.64%, an operating margin of -5.07%, a net margin of -6.05%, a Return on Equity (ROE) of -21.36%, a Return on Assets (ROA) of -10.05%, and a Return on Invested Capital (ROIC) of -15.91%. Per share, it reports EPS of $-0.03, diluted EPS of $-0.03, free cash flow per share of $-0.04, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -2.97% year-over-year, net income growth of -44.95% year-over-year, and EPS growth of -53.92% year-over-year. On the balance sheet, it maintains a current ratio of 2.28x, a quick ratio of 0.78x, working capital of $1.38M, a debt-to-equity ratio of 1.18x, a debt ratio of 0.54, an interest coverage ratio of -5.69x, free cash flow of $-558.71K (TTM), and net debt of $157.43K. Figures sourced from SEC EDGAR.

Market Cap

$5.48M

P/E TTM

-14.38x

EPS TTM

$-0.03

P/B TTM

2.94x

ROE TTM

-21.36%

ROA TTM

-10.05%

Debt To Equity

1.18x

Free Cash Flow TTM

$-558.71K

Net Revenue TTM Growth 1Y

-2.97%

Data as of 2025-09-30 · Source: SEC EDGAR